From July 1, 2022 to September 30, 2022, the company has repurchased 1,416,480 shares, representing 0.73% for CNY 57.76 million. With this, the company has completed the repurchase of 2,546,351 shares, representing 1.31% for CNY 102.03 million under the buyback announced on May 6, 2022.
Shanghai ZJ Bio-Tech Co., Ltd
Equities
688317
CNE100005DB6
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.41 CNY | +0.14% |
|
-2.83% | -31.32% |
06-24 | Shanghai ZJ Bio-Tech Co., Ltd(XSSC:688317) dropped from S&P Global BMI Index | CI |
04-28 | Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-31.32% | 380M | |
-11.78% | 11.24B | |
-13.76% | 7.29B | |
+29.50% | 5.57B | |
-0.19% | 5.31B | |
-19.19% | 3.68B | |
+7.62% | 2.58B | |
-65.24% | 2.33B | |
-10.48% | 2.23B | |
+27.80% | 2.21B |
- Stock Market
- Equities
- 688317 Stock
- News Shanghai ZJ Bio-Tech Co., Ltd
- Tranche Update on Shanghai ZJ Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022.